Support WBURPfizer's Rheumatoid Arthritis Pill Shows Promise In Big StudiesScott HensleyNovember 08, 2010 SharePfizer's experimental rheumatoid arthritis drug targets the JAK3 protein, which looks like this. (Wikimedia Commons)